Morphosys: Biotech pioneer in the crisis of confidence

Why copying your stock purchases is dangerous

Why copying your stock purchases is dangerous

Why copying your stock purchases is dangerous

Morphosys makes a loss of half a billion euros

Cheplapharm is about to go public with billions

Warren Buffett is now betting on these two stocks